Drug Shortage Report for ACT PRAMIPEXOLE
Report ID | 190725 |
Drug Identification Number | 02297337 |
Brand name | ACT PRAMIPEXOLE |
Common or Proper name | ACT-PRAMIPEXOLE 1.5MG TABLETS 100 |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE |
Strength(s) | 1.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N04BC |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-04-27 |
Estimated end date | 2024-01-31 |
Actual end date | 2024-01-10 |
Shortage status | Resolved |
Updated date | 2024-01-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2024-01-11 | French | Compare |
v18 | 2024-01-11 | English | Compare |
v17 | 2023-12-07 | French | Compare |
v16 | 2023-12-07 | English | Compare |
v15 | 2023-11-09 | French | Compare |
v14 | 2023-11-09 | English | Compare |
v13 | 2023-10-26 | French | Compare |
v12 | 2023-10-26 | English | Compare |
v11 | 2023-10-04 | French | Compare |
v10 | 2023-10-04 | English | Compare |
v9 | 2023-07-18 | French | Compare |
v8 | 2023-07-18 | English | Compare |
v7 | 2023-07-06 | French | Compare |
v6 | 2023-07-06 | English | Compare |
v5 | 2023-06-08 | French | Compare |
v4 | 2023-06-08 | English | Compare |
v3 | 2023-04-28 | English | Compare |
v2 | 2023-04-27 | French | Compare |
v1 | 2023-04-27 | English | Compare |
Showing 1 to 19 of 19